FR2213776A1 - Preparations for relieving skin disorders - characterized by accelerated skin cell division with incomplete tissue differentiation - Google Patents

Preparations for relieving skin disorders - characterized by accelerated skin cell division with incomplete tissue differentiation

Info

Publication number
FR2213776A1
FR2213776A1 FR7401336A FR7401336A FR2213776A1 FR 2213776 A1 FR2213776 A1 FR 2213776A1 FR 7401336 A FR7401336 A FR 7401336A FR 7401336 A FR7401336 A FR 7401336A FR 2213776 A1 FR2213776 A1 FR 2213776A1
Authority
FR
France
Prior art keywords
dermatitis
preparations
cell division
tissue differentiation
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7401336A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VOORHEES JOHN US
Original Assignee
VOORHEES JOHN US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VOORHEES JOHN US filed Critical VOORHEES JOHN US
Publication of FR2213776A1 publication Critical patent/FR2213776A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical prepns. consisting essentially of a pharmaceutical carrier and an effective amt. of at least one of a wide range of specified active ingredients (ranging from e.g. xanthine derivs. to chlordiazepoxide, aldosterone or erythritol tetranitrate) may be administered therapeutically or prophylactically, topically, parenterally, intralesionally, intradermally, subcutaneously or orally for the relief of disorders such as psoriasis, atopic dermatitis, non-specific dermatitis, primary contact dermatitis, basal and lamellar skin carcinoma, lamellar ichthyosis, epidermolytic hyperkeratosis, precancerous solar keratosis, non-cancerous keratosis, acne or seborrhoeic dermatitis in man or mange in domestic animals.
FR7401336A 1973-01-16 1974-01-15 Preparations for relieving skin disorders - characterized by accelerated skin cell division with incomplete tissue differentiation Withdrawn FR2213776A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32401273A 1973-01-16 1973-01-16
US42506573A 1973-12-17 1973-12-17

Publications (1)

Publication Number Publication Date
FR2213776A1 true FR2213776A1 (en) 1974-08-09

Family

ID=26984233

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7401336A Withdrawn FR2213776A1 (en) 1973-01-16 1974-01-15 Preparations for relieving skin disorders - characterized by accelerated skin cell division with incomplete tissue differentiation

Country Status (3)

Country Link
BE (1) BE809832A (en)
DE (1) DE2401446A1 (en)
FR (1) FR2213776A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104782A2 (en) * 1982-08-30 1984-04-04 Ortho Pharmaceutical Corporation A pharmaceutical composition for topical application for treating atopic dermatitis
EP0428313A2 (en) * 1989-11-13 1991-05-22 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US8148327B2 (en) * 2007-06-06 2012-04-03 Human Matrix Sciences, Llc Aldosterone induced elastin production
US8618084B2 (en) 2008-06-06 2013-12-31 Human Matrix Sciences, Llc Aldosterone induced vascular elastin production

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172565A (en) * 1980-04-25 1984-08-14 Alfred Boris Anti-inflammatory methods and compositions

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104782A2 (en) * 1982-08-30 1984-04-04 Ortho Pharmaceutical Corporation A pharmaceutical composition for topical application for treating atopic dermatitis
EP0104782A3 (en) * 1982-08-30 1985-06-05 Ortho Pharmaceutical Corporation A pharmaceutical composition for topical application for treating atopic dermatitis
EP0428313A2 (en) * 1989-11-13 1991-05-22 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
EP0428313A3 (en) * 1989-11-13 1991-11-06 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5342842A (en) * 1989-11-13 1994-08-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US8148327B2 (en) * 2007-06-06 2012-04-03 Human Matrix Sciences, Llc Aldosterone induced elastin production
US8470774B2 (en) 2007-06-06 2013-06-25 Human Matrix Sciences, Llc Deoxycorticosterone induced elastin production
US9492462B2 (en) 2007-06-06 2016-11-15 Human Matrix Sciences, Llc Composition for elastin production
US8618084B2 (en) 2008-06-06 2013-12-31 Human Matrix Sciences, Llc Aldosterone induced vascular elastin production
US9283236B2 (en) 2008-06-06 2016-03-15 The Hospital For Sick Children Aldosterone induced vascular elastin production

Also Published As

Publication number Publication date
BE809832A (en) 1974-07-16
DE2401446A1 (en) 1974-07-25

Similar Documents

Publication Publication Date Title
GB1382815A (en) Electrical connectors
GB1522149A (en) Purification of nutritive glyceride oils
FR2213776A1 (en) Preparations for relieving skin disorders - characterized by accelerated skin cell division with incomplete tissue differentiation
GB1158370A (en) Process for Isomerizing and Purifying Hop Extracts
JPS5248441A (en) Memory system
GB960406A (en) Improvements in or relating to electric circuit-breakers
GB1142804A (en) Medicaments based on avocado oil and/or soya oil
Zacharias Quantitativer Vergleich von berechneten und gemessenen Elektronen-Energieverlustspektren an Silber
GB1301603A (en)
Ayres et al. Demodex folliculorum in rosacea
JPS5675421A (en) Beautifying lotion
GB743173A (en) Improvements in screwed fastenings
JPS5483910A (en) Production of fats and oils for foods
JPS5327126A (en) Piping coupling of roll bearing part for rolling mill
FR2104911A1 (en) Heterosides from ruscus aculeatus l - useful as antiinflammatories vasconstructors and fibrinolytics
JPS5351209A (en) Additives for mixtures of pulverized coals and oils
JPS51140119A (en) Cooling system for eletric machinery
FR2213777A1 (en) Nucleoside cyclic phosphate compsns. - for relieving skin proliferation diseases
GB1292794A (en) Pharmaceutical compositions
Olson et al. Dyskeratosis in Bowen's disease.
Nagahara Supplements to the previous paper" Quasi-Galois extensions of simple rings"
JPS533592A (en) Separation of protein from yeast cells
JPS55164412A (en) Bolt clipper
INABA et al. Some experiments on the utilization of whale meat as a diet of the eel culture (Preliminary)
USD130232S (en) Pharmaceutical product selector and dosage calculator

Legal Events

Date Code Title Description
ST Notification of lapse